“Anti-CGRP Monoclonal Antibodies Improve Cognitive Function in Patients Affected by Chronic Migraine Complicated With Medication Overuse-Headache”. 2024. Confinia Cephalalgica 34 (1). https://doi.org/10.4081/cc.2024.15760.